Two Sigma Investments LP Has $33.05 Million Holdings in STERIS plc (NYSE:STE)

Two Sigma Investments LP lifted its stake in shares of STERIS plc (NYSE:STE - Free Report) by 270.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,778 shares of the medical equipment provider's stock after acquiring an additional 117,404 shares during the period. Two Sigma Investments LP owned 0.16% of STERIS worth $33,050,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. State of Wyoming raised its holdings in STERIS by 102.5% in the fourth quarter. State of Wyoming now owns 1,950 shares of the medical equipment provider's stock valued at $401,000 after buying an additional 987 shares during the period. Select Equity Group L.P. grew its position in shares of STERIS by 165.3% during the fourth quarter. Select Equity Group L.P. now owns 2,599,730 shares of the medical equipment provider's stock worth $534,400,000 after buying an additional 1,619,796 shares in the last quarter. Skye Global Management LP grew its position in shares of STERIS by 76.2% during the fourth quarter. Skye Global Management LP now owns 29,600 shares of the medical equipment provider's stock worth $6,085,000 after buying an additional 12,800 shares in the last quarter. SGL Investment Advisors Inc. grew its position in shares of STERIS by 3.3% during the fourth quarter. SGL Investment Advisors Inc. now owns 11,309 shares of the medical equipment provider's stock worth $2,478,000 after buying an additional 360 shares in the last quarter. Finally, Sherbrooke Park Advisers LLC acquired a new stake in shares of STERIS during the fourth quarter worth approximately $603,000. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

STERIS Trading Down 0.2%

STE traded down $0.59 during trading on Friday, reaching $243.21. The company had a trading volume of 538,496 shares, compared to its average volume of 543,647. The firm's 50-day simple moving average is $226.25 and its 200 day simple moving average is $220.06. The company has a market cap of $23.90 billion, a price-to-earnings ratio of 51.64 and a beta of 0.96. STERIS plc has a 12-month low of $200.98 and a 12-month high of $252.79. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. The firm had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.47 billion. STERIS had a return on equity of 13.91% and a net margin of 8.66%. STERIS's revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $2.58 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be paid a $0.57 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 0.94%. STERIS's payout ratio is 36.77%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on STE shares. JMP Securities raised their price objective on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a research note on Friday, May 16th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Morgan Stanley raised their target price on STERIS from $240.00 to $260.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Wall Street Zen upgraded shares of STERIS from a "buy" rating to a "strong-buy" rating in a research note on Thursday. Finally, Stephens restated an "overweight" rating and set a $250.00 price objective on shares of STERIS in a research note on Thursday, May 15th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, STERIS has an average rating of "Moderate Buy" and a consensus price target of $264.00.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.